Becton Dickinson (BDX)
Health Care · Medical devices and diagnostics
A global medical technology leader producing diagnostic devices, infusion systems, and other healthcare solutions serving hospitals, laboratories, and patients worldwide.
What Becton Dickinson does
Becton Dickinson is a diversified global medical technology company that manufactures and distributes a broad range of medical devices, diagnostic equipment, and healthcare solutions. The company operates across diagnostic systems, infusion therapy products, pharmaceutical systems, and other medical devices serving hospitals, clinical laboratories, blood banks, and patients. BD generates revenue through product sales to healthcare providers and medical facilities globally, with operations spanning multiple geographies and serving both acute and chronic care markets.
Themes: ["Medical devices","Diagnostic systems","Infusion therapy","Healthcare infrastructure","Drug delivery","Hospital equipment","Clinical diagnostics","Patient safety devices"]
Fundamentals
- Price$150.85 as of 2026-07-09 close
- Market cap$41.5B as of 2026-07-10
- 1-year return+9.7% as of 2026-07-09 close
- P/E36.47 as of 2026-07-10
- Net margin+5.3% as of 2026-07-10
- Gross margin+47.0% as of 2026-07-10
- ROE+4.5% as of 2026-07-10
- Debt / equity0.72 as of 2026-07-10
- Revenue growth (YoY)+2.4% as of 2026-07-10
- Revenue CAGR (3y)+5.0% SEC XBRL
- Beta0.21 as of 2026-07-10
Dividend: yield +2.8%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Integration and restructuring expenses represent significant operating costs ($640M in first half of 2026), indicating ongoing transformation challenges and potential execution risk from acquisitions or divestitures","Discontinued operations generated $202M loss in the first six months of 2026, suggesting previous divestiture or spin-off created headwinds to profitability and disrupted operational continuity","Elevated debt levels ($17.3B in total debt as of March 31, 2026) combined with modest revenue growth (2.39% YoY) creates financial leverage risk and may limit strategic flexibility"]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.